Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce A Feinberg

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Journal of Oncology Practice|September 4, 2012
Implementation of cancer clinical care pathways: a successful model of collaboration between payers and providersBruce A Feinberg, James Lang, James Grzegorczyk, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 15, 2023
Real-World Use of Fedratinib for Myelofibrosis Following Prior Ruxolitinib Failure: Patient Characteristics, Treatment Patterns, and Clinical OutcomesJohn Mascarenhas, Claire Harrison, Tammy A Schuler, et al.
Journal of Comparative Effectiveness Research|March 12, 2026
A novel real-world data methodology for lymphoma outcome classification: the real-world Lugano studyRichard Scott Swain, Andrew Klink, Parisa Asgarisabet, et al.
International Journal of Oncology|November 20, 2013
Angiogenesis inhibitor therapies for advanced renal cell carcinoma: toxicity and treatment patterns in clinical practice from a global medical chart reviewWilliam K Oh, David McDermott, Camillo Porta, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Journal of Oncology Practice|September 4, 2012
Implementation of cancer clinical care pathways: a successful model of collaboration between payers and providersBruce A Feinberg, James Lang, James Grzegorczyk, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 15, 2023
Real-World Use of Fedratinib for Myelofibrosis Following Prior Ruxolitinib Failure: Patient Characteristics, Treatment Patterns, and Clinical OutcomesJohn Mascarenhas, Claire Harrison, Tammy A Schuler, et al.
Journal of Comparative Effectiveness Research|March 12, 2026
A novel real-world data methodology for lymphoma outcome classification: the real-world Lugano studyRichard Scott Swain, Andrew Klink, Parisa Asgarisabet, et al.
International Journal of Oncology|November 20, 2013
Angiogenesis inhibitor therapies for advanced renal cell carcinoma: toxicity and treatment patterns in clinical practice from a global medical chart reviewWilliam K Oh, David McDermott, Camillo Porta, et al.
Pageof 5